Minims Fenilefrina Hidrocloruro Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine hydrochloride selectively stimulates alpha‑1 adrenergic receptors on conjunctival blood vessels, causing vasoconstriction. This reduces blood flow to the superficial vessels, decreasing the appearance of redness and providing rapid visual relief.

The prescribed dose of Minims Fenileprina is determined by the treating clinician based on the patient’s condition, age, and response. Typical regimens involve one to two drops per eye, not exceeding the frequency recommended on the product label.

Safety data for phenylephrine ophthalmic use in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against risks and consider alternative treatments if uncertainty exists.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Phenylephrine is a selective alpha‑1 agonist, offering rapid vasoconstriction with a short duration of action. Compared with naphazoline or tetrahydrozoline, phenylephrine may have a slightly lower risk of rebound redness but similar efficacy for short‑term relief.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct sunlight, and retain it in the original packaging to avoid moisture exposure.

The product is applied topically to the eye. After washing hands, tilt the head back, gently pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. Close the eye briefly to allow distribution.

Serious risks include severe allergic reactions such as anaphylaxis, significant elevation of intraocular pressure that could precipitate glaucoma, and rare corneal edema. Patients should seek immediate medical attention if they experience sudden pain, vision changes, or swelling.

Individuals with known hypersensitivity to phenylephrine or any formulation component, patients with narrow‑angle glaucoma, uncontrolled hypertension, or those taking MAO inhibitors should avoid using this product unless directed by a physician.